Overview
The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.
Description
The study aims to utilize qualitative measurements, including pre- and post-treatment breast and prostate cancer surveys tailored to specific ethnic groups-Native American, African American, and Hispanic/Latino populations. In addition to these culturally relevant surveys, participants will also complete the COST-Functional Assessment of Chronic Illness Therapy (COST-FACT) score to evaluate the financial and functional impact of their cancer care experience.
Those who choose to complete the surveys will be offered navigation assistance as part of the study intervention.
Eligibility
Inclusion Criteria:
- Subjects must have histologically or cytologically confirmed Breast or Prostate Cancer.
- Subjects must be 18 years of age or older. This study requires informed consent by the subject.
- Subjects must be of African American race, Native American race, or Hispanic ethnicity.
- Subjects scheduled to undergo RT for Cancer Treatment.
- Subjects must have the ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
- Subjects NOT of African American race, Native American race or Hispanic ethnicity.
- Subjects WITHOUT histologically/cytologically confirmed Breast or Prostate Cancer.
- Subjects younger than 18 years old.